Early Insulin Initiation in Type 2 Diabetes Is Essential
May 9, 2020
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Taylor-Eugene Simmons, Florida A&M University, College of Pharmacy & Pharmaceutical Sciences, PharmD Candidate
At the Cardiometabolic Health Congress in Chicago, October 10-13th, 2019, Irl B. Hirsch, MD, professor of medicine at the University of Washington in Seattle, presented the theory of introducing insulin earlier to improve therapeutic outcomes in patients with type 2 diabetes. According to Hirsh, health providers who treat these patients need to include insulin amongst other antidiabetic medication options earlier in the treatment process. Hirsch stated that although insulin's role was different than it was before the introduction of SGLT2 inhibitors and GLP-1 receptor agonists, it remains a vital part of treatment for type 2 diabetes.
The majority of patients with type 2 diabetes fail to maintain glycemic goals over time after a successful initial response to therapy from weight reduction, diet, and oral medication (usually metformin)....
Agreement to pay later is required for access to the full text of this article. You will be charged only after your use reaches $5.00 (US) of site content. The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.